KATHERINE MANZANARES: Open Payments
NPI 1316040660 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,530 in 71 payments from 17 companies in 2025. Trend: 2023 $14 · 2024 $1,511 · 2025 $1,530
Food & beverage: $1,530
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $310 |
| AstraZeneca Pharmaceuticals LP | 10 | $223 |
| Novo Nordisk Inc | 11 | $200 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $159 |
| ABBVIE INC. | 7 | $141 |
| Corcept Therapeutics | 3 | $71 |
| Amgen Inc. | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| Exact Sciences Corporation | 3 | $62 |
| Lilly USA, LLC | 3 | $56 |
Products named: Kerendia, PREVNAR 20, AIRSUPRA, NURTEC ODT, UBRELVY, Wegovy, Korlym, Ozempic.
Industry payments across VA — which companies pay providers there.
